Principal Financial Group Inc. Acquires 7,127 Shares of Tenet Healthcare Corporation $THC

Posted by Geri Gentry on Jul 19th, 2026

Principal Financial Group Inc. grew its holdings in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 3.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 196,092 shares of the company’s stock after acquiring an additional 7,127 shares during the quarter. Principal Financial Group Inc.’s holdings in Tenet Healthcare were worth $37,005,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Triumph Capital Management purchased a new position in Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the 4th quarter worth $26,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare in the fourth quarter worth $29,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter valued at $35,000. Finally, Meeder Asset Management Inc. lifted its stake in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Price Performance

THC opened at $194.89 on Friday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21. The stock’s 50 day simple moving average is $184.35 and its 200 day simple moving average is $197.48. The firm has a market cap of $16.79 billion, a price-to-earnings ratio of 10.13, a PEG ratio of 1.61 and a beta of 1.27.

Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the prior year, the firm posted $4.36 earnings per share. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, analysts predict that Tenet Healthcare Corporation will post 17.5 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently commented on THC shares. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a research report on Friday, May 1st. KeyCorp cut their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Stephens decreased their price target on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. TD Cowen lowered their price objective on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Finally, Robert W. Baird reduced their target price on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $245.37.

Check Out Our Latest Report on Tenet Healthcare

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.97% of the company’s stock.

About Tenet Healthcare

(Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.